Summary
The European Food Safety Authority (EFSA) asked the Panel on Biological Hazards (BIOHAZ) to deliver a scientific opinion on the maintenance of the list of qualified presumption of safety (QPS) biological agents intentionally added to food or feed. The request included three specific tasks as mentioned in the Terms of Reference (ToR).
In 2014, the BIOHAZ Panel decided to change the evaluation procedure: instead of publishing the overall assessment of the taxonomic units previously recommended for the QPS list annually, as prior to 2013, it will be now carried out after 3 years in a scientific opinion of the BIOHAZ Panel (December 2016) . Meanwhile, that list of microorganisms will be maintained and frequently checked based on the evaluation of extensive literature searches that will be updated regularly with data from new publications. Intermediate deliverables in the form of a Panel Statement will be produced and published, should an assessment for a QPS classification of a microbiological agent notified to EFSA be requested by the Feed Unit, the Food Ingredients and Packaging (FIP) Unit, the Nutrition Unit or the Pesticides Unit. Evaluations of these notifications will be compiled in a single Statement for periods of around 6 months. The main results of these assessments will also be included in the scientific opinion of the BIOHAZ Panel to be published in December 2016. The '2013 updated list of QPS status recommended biological agents for safety risk assessments carried out by EFSA scientific Panels and Units' will be updated with the inclusion of new recommendations for the QPS status and is appended to each new Panel Statement.
The first ToR requires ongoing updates of the list of biological agents being notified, in the context of a technical dossier to EFSA Units (such as Feed, FIP, Nutrition and Pesticides), for intentional use in food and/or feed or as sources of food and feed additives, enzymes and plant protection products. The list was updated with the notifications received since the latest review and the new ones were included in a table appended to the current Statement (Appendix C). Notifications considered for the current Statement were received between September 2015 and March 2016. Within this period, 129 notifications were received from those four Units, of which 21 were from Feed, 67 from FIP, two from Nutrition and 39 from Pesticides.
The second ToR concerns the revision of the taxonomic units previously recommended for the QPS list and their qualifications (especially the qualification regarding antimicrobial resistance) when new information has become available and to update the information provided in the previous Opinion published in November 2013 where appropriate. The work being developed in order to meet this ToR is not reflected in the current Statement, but will be published in a scientific opinion of the BIOHAZ Panel, in December 2016.
The third ToR requires a (re)assessment of the suitability of taxonomic units notified to EFSA not present in the current QPS list for their inclusion in the updated list. The current Statement focuses on this ToR by including the individual assessments of the taxonomic units not previously included in the 2013 QPS list and that were notified to EFSA between September 2015 and March 2016. Of the 129 notifications received, 34 biological agents already had a QPS status and did not require further evaluation in this Statement. From the remaining 95 (without a QPS status), 63 were not further assessed as they are filamentous fungi or enterococci, biological groups which have been excluded from QPS activities since 2014. Five notifications for species belonging to Streptomyces genus, one for a species of Actinomadura and one for Paenibacillus lentus, were not included because the corresponding taxonomic units have already been evaluated in the previous Statement of December of 2014 and found unsuitable for QPS. Four notifications of strains belonging to the species Escherichia coli were not included because the species had also been re-evaluated in the previous Statement and was considered not suitable for the QPS approach. Furthermore, it was agreed not to include nine notifications from Pesticides Unit as the respective dossiers (including the literature review) were not yet received. Twelve notifications were assessed for the suitability of the respective taxonomic units for inclusion on the QPS list. Lactobacillus diolivorans and Pediococcus parvulus were notified to the Feed Unit and Bacillus flexus, Cellulosimicrobium cellulans, 'Chryseobacterium proteolyticum', Geobacillus caldoproteolyticus (Anoxybacillus caldiproteolyticus), Aeribacillus pallidus (ex-Geobacillus pallidus), Klebsiella pneumoniae, Paenibacillus macerans, 'Protaminobacter rubrum', Pullulanibacillus naganoensis and Candida rugosa were notified to the FIP Unit. After the assessment, which is included in the current Statement, Lactobacillus diolivorans and Pediococcus parvulus may be recommended for the QPS status. Bacillus flexus may be also recommended but with a qualification of the absence of toxigenic activity (applied to all strains of Bacillus species recommended to the QPS list). Candida rugosa, Cellulosimicrobium cellulans, Geobacillus caldoproteolyticus (Anoxybacillus caldiproteolyticus), Aeribacillus 
Introduction
A wide variety of microorganisms are intentionally added at different stages into the food chain, either directly or as a source of food and feed additives, enzymes or plant protection products. In the context of applications for market authorisation of these biological agents, the European Food Safety Authority (EFSA) is requested to assess their safety. The qualified presumption of safety (QPS) approach was developed by the EFSA Scientific Committee to provide a generic concept to prioritise and to harmonise risk assessment within EFSA of microorganisms intentionally introduced into the food chain, in support of the respective Scientific Panels and Units in the frame of authorisations (EFSA, 2007) . The list, first established in 2007, has been revised and updated. Taxonomic units were included in the QPS list either following notifications to EFSA or following proposals made by stakeholders during a public consultation in 2005, even if they were not yet notified to EFSA (EFSA, 2005) . For the 2014 update, it was decided to change the procedures. The publication of the overall assessment of the taxonomic units previously recommended for the QPS list (EFSA BIOHAZ Panel, 2013) will be carried out every 3 years through a scientific opinion by the Panel on Biological Hazards (BIOHAZ). In any case, the recommendations provided concerning that list of microorganisms will be maintained and frequently checked based on the evaluation of extensive literature reviews which will be updated regularly with new publications. Intermediate deliverables in the form of a Panel Statement will be produced and published, should an assessment for a QPS classification of a microbiological agent notified to EFSA be requested by Feed, Food Ingredients and Packaging (FIP), Nutrition or Pesticides units. Evaluations of these notifications will be compiled in single Statements for periods of around 6 months. The results of these assessments will also be included in the scientific opinion to be published in December of 2016. The '2013 updated list of QPS status recommended biological agents for safety risk assessments carried out by EFSA Scientific Panels and Units' to which new recommendations of taxonomic units for the QPS will be included, and will be appended to each Panel Statement.
QPS entered the European Union (EU) law with the publication of a new Commission Implementing Regulation (EU) No 562/2012
1 amending Commission Regulation (EU) No 234/2011 2 with regard to specific data required for risk assessment of food enzymes. If the microorganism used in the production of a food enzyme has a status of QPS according to the most recent list of QPS recommended biological agents adopted by the EFSA, the enzyme application should not be required to include toxicological data. If residues, impurities and degradation products linked to the total enzyme production process (production, recovery and purification) could give rise for concern, the Authority, pursuant to Article 6(1) of Regulation (EC) No 1331/2008, 3 may request additional data for risk assessment, including toxicological data.
1.1.
Background and Terms of Reference as provided by EFSA
Background as provided by EFSA
A wide variety of microorganisms are intentionally added at different stages into the food chain, either directly or as a source of additives or food enzymes or plant protection products. EFSA is requested to assess the safety of these biological agents in the context of applications received by EFSA for market authorisation as sources of food and feed additives, enzymes and plant protection products.
The Scientific Committee reviewed the range and numbers of microorganisms likely to be the subject of an EFSA Opinion and in 2007 published a list of microorganisms recommended for QPS, 4, 5 consisting of 48 species of Gram-positive non-sporulating bacteria, 13 Bacillus species and 11 yeast species. Filamentous fungi were also assessed but none was recommended for QPS status. The Scientific Committee recommended that a QPS approach should be implemented across EFSA and applied equally to all safety considerations of microorganisms that EFSA is required to assess. The Scientific Committee recognised that there would have to be continuous provision for reviewing and modifying the QPS list. The BIOHAZ Panel took the prime responsibility for this and annually reviewed the existing QPS list as recommended by the Scientific Committee.
In the first annual QPS review and update, 6 the existing QPS list was reviewed and EFSA's initial experience in applying the QPS approach was described. The potential application of the QPS approach to microbial plant protection products was discussed in the 2009 review.
7 In 2009, viruses and bacteriophages were assessed for the first time leading to the addition of two virus families used for plant protection purposes to the QPS list. Bacteriophages were not considered appropriate for the QPS list. After consecutive years of updating the existing scientific knowledge, the filamentous fungi (2008-2013 updates) and enterococci (2010-2013 updates) were not recommended for the QPS list.
The 2013 update of the recommended QPS list includes 53 species of Gram-positive nonsporulating bacteria, 13 Gram-positive spore-forming bacteria (Bacillus species), one Gram-negative bacterium (Gluconobacter oxydans), 13 yeast species and three virus families. No QPS recommended species has been taken down from the list following six (2008-2013 updates) annual reviews.
Based on the above information, the BIOHAZ Panel at their plenary meeting in January 2014 made a proposal for future QPS activities that was discussed at the Scientific Committee meeting in March 2014. The Scientific Committee agreed to exclude some biological groups (filamentous fungi, bacteriophages and enterococci) in future QPS activities, while an extensive literature review of the QPS recommended list could be done less frequently. The deadline for the assessment of the suitability of new taxonomic units notified to EFSA for inclusion in the QPS list would be tailored to the needs of the requesting EFSA Units and/or Scientific Panels.
Terms of Reference as provided by EFSA
ToR 1: Keep updated the list of biological agents being notified, in the context of a technical dossier to EFSA Units (such as Feed, Pesticides, Food Ingredients and Packaging and Nutrition), for intentional use in food and/or feed or as sources of food and feed additives, enzymes and plant protection products.
ToR 2: Review taxonomic units previously recommended for the QPS list and their qualifications (especially the qualification regarding antimicrobial resistance) when new information has become available. Update the information provided in the previous opinion where appropriate.
ToR 3: (Re)assess the suitability of taxonomic units notified to EFSA not present in the current QPS list for their inclusion in that list.
2.
Data and methodologies
Data
For the taxonomic units associated with the notifications compiled within the time period covered by this Statement (from end of September 2015 until March 2016), the literature review considered the identity, the body of knowledge, history of use and the potential safety concerns.
Relevant databases, such as PubMed, Web of Science, CasesDatabase, CAB Abstracts or Food Science Technology Abstracts (FSTA), Scopus were searched. More details on the search strategy, search keys and approach followed are described in Appendix A.
In February 2016, it was agreed to improve the assessment of the QPS status and its applicability for the Pesticide Unit by taking into account the data provided to EFSA within the applicant's dossier (that is required to include an extensive systematic literature review of the peer reviewed scientific literature). This will bring additional experts' views on specific issues related to microorganisms being evaluated. 
Methodologies
In response to ToR1, the EFSA Units have been asked to update the list of biological agents being notified to EFSA. A total of 129 notifications were received between September 2015 and March 2016, of which 21 from Feed, 67 from FIP, two from Nutrition and 39 from Pesticides (Table 1) .
In response to ToR3, from those 129 notifications, 34 biological agents already had a QPS status and did not require further evaluation; neither did the 63 biological agents that are filamentous fungi or enterococci, which have been excluded from QPS activities (in the follow up of a recommendation of the QPS 2013 update (EFSA BIOHAZ Panel, 2013 . Five notifications for species belonging to Streptomyces genus, one for a species of Actinomadura and one for Paenibacillus lentus were also not included because they have already been evaluated in the Statement of December 2014 and were found unsuitable for QPS (EFSA BIOHAZ Panel, 2014) . Four notifications of strains belonging to Escherichia coli were not included as this species has been previously re-evaluated and found unsuitable for QPS (EFSA BIOHAZ Panel, 2014) . Furthermore, it was agreed with the Pesticides Unit (see explanation above) not to include nine notifications as the respective dossiers (including the literature review) were not yet received. Twelve biological agents were assessed for their suitability for inclusion in the QPS list as the species were not previously assessed. They were notified to the Feed Unit (Lactobacillus diolivorans, Pediococcus parvulus) and to the FIP Unit (Bacillus flexus, Cellulosimicrobium cellulans, 'Chryseobacterium proteolyticum', Geobacillusc caldoproteolyticus (Anoxybacillus caldiproteolyticus), Aeribacillus pallidus (ex-Geobacillus pallidus), Klebsiella pneumoniae, Paenibacillus macerans, 'Protaminobacter rubrum', Pullulanibacillus naganoensis and Candida rugosa). Streptomyces genus were not included because they have already been evaluated in the previous Statement of December of 2014 and found unsuitable for QPS (EFSA BIOHAZ Panel, 2014) . Four notifications corresponding to four strains of E. coli were not included as the species has been previously evaluated and found unsuitable for QPS (EFSA BIOHAZ Panel, 2014) . One notification corresponding to Actinomadura roseorufa and one to Paenibacillus lentus were not included because it was already evaluated in December 2014.
The procedure followed for this assessment is the same as in the previous QPS 2013 update of the scientific Opinion (EFSA BIOHAZ Panel, 2013) Bacillus flexus was originally described by Batchelor (1919) , and validated as revived species name (sp. nov., nom. rev.) by Priest et al. (1988) . B. flexus is most closely related to Bacillus paraflexus (16S rRNA gene sequence similarity 98.1%), although also phylogenetically closely related to Bacillus nealsonii (95%), Bacillus niabensis (95%) and Bacillus azotoformans (94%) (Chandna et al., 2013) . B. flexus can be identified through 16S rRNA gene sequencing and differentiated from its closest phylogenetic neighbour B. paraflexus with standard phenotypic tests.
Body of knowledge
Bacillus flexus has been used for production of enzymes, e.g. b-amylase in food production 8 and of alkaline amylase, lipase and protease for detergent formulations (Niyonzima and More, 2014). It has also been used for the production of exopolysaccharides (EPS) (Singh et al., 2013) and for bioremediation (Sivaprakasam et al., 2008; Pal et al., 2014; Das et al., 2016) . Zhang et al. (2014) sequenced the whole genome of B. flexus strain T6186-2 isolated from the formation water sample of an oilfield.
Safety concerns
A recent outbreak of wound infections in burned patients was reported (Uc ßar et al., 2016). The outbreak was associated with contaminated swabs for wound sampling. Isolate identification procedures and virulence features characterisation were not presented in the study, neither was the relation between the infection and the B. flexus strain. To our knowledge, there are no reports of any virulence feature or disease associated with B. flexus, further supporting the absence of pathogenicity potential in a non-compromised host.
Antimicrobial resistance
Genes encoding resistance to vancomycin (vanB), fosfomycin (fosB) and tetracycline (tetA) were described in a B. flexus strain (Zhang et al., 2014) . Nevertheless, it was not possible from the data presented to assess if these genes are part of the chromosomal core genome and therefore present in all members of this species or associated with mobile resistance elements. Moreover, it is not possible to infer if they confer resistance to the mentioned antimicrobials.
Conclusions on a recommendation for the QPS list
Bacillus flexus can be recommended for the QPS list with a qualification of absence of toxigenic activity (as applied to all strains of Bacillus species recommended to the QPS list).
3.2.
Cellulosimicrobium cellulans
Identity
The genus Cellulosimicrobium was first proposed by Schumann et al. (2001) for the bacterium previously classified as Cellulomonas cellulans (basonym Nocardia cellulans, embracing the misclassified species Cellulomonas cartae, Brevibacterium lyticum, Brevibacterium fermentans, Arthrobacter luteus and Oerskovia xanthineolytica). 16S rDNA sequencing and the unique combination of chemotaxonomic properties led to the reclassification of this Gram-positive rod to the genus Cellulosimicrobium of the family Promicromonosporaceae, suborder Micrococcineae, order Actinomycetales, class Actinobacteria.
Currently, two sequenced genomes of C. cellulans LMG 16121 (NZ_CAOI00000000.1) and C. cellulans J36 (NZ_JAGJ00000000.1) are available.
Body of knowledge
The ecological distribution of Cellulosimicrobium strains not only includes mainly mesophilic environments, such as soil, marine sponges and clinical materials, but also extreme environments, including hot springs (Sharma et al., 2014) and Antarctic snow (Antony et al., 2009) . Different enzymes with relevant activity have been described in C. cellulans strains, including chitinase (Fleuri et al., 2009 ), b-1,4-xylanase (Walia et al., 2014) , proteases and b-1,3-glucanase. The glucanase activity could be useful for the degradation of cell wall in fungi, yeasts and higher plants. Applications of b-1,3-glucanases includes clarification of slimy must, degradation of barley b-glucan that accumulates during the brewing process, as feed additives in animal production and in treatment of fungal diseases (Pang et al., 2004) .
Safety concerns
Cellulosimicrobium cellulans is a rare opportunistic pathogen in humans causing infections (bacteraemia, peritonitis, endocarditis and infections in other tissues, e.g. joints, ocular and soft tissue) mostly in patients with immunocompromised status and the presence of a foreign body (Rowlinson et al., 2006; Magro-Checa et al., 2011; Petkar et al., 2011; Sug Kim et al., 2015) . Recent analysis of two available C. cellulans genomes (LMG 16121 and J36) revealed 49 genes with known association with a human pathogenicity potential (Sharma et al., 2016) . These genes were associated with pathogenicity islands which are not known to be present in C. cellulans strains. Equine abortion and premature birth associated with C. cellulans infection have also been described (Bolin et al., 2004) .
Antimicrobial resistance
Cellulosimicrobium cellulans strains have been described as resistant to penicillins, aminoglycosides, macrolides and cephalosporins (Harrington et al., 1996; Petkar et al., 2011) . No data are available on the presence of genetic determinants for antimicrobial resistance in C. cellulans.
Conclusions on a recommendation for the QPS list
Safety concerns regarding Cellulosimicrobium cellulans have not excluded the possibility of ill effects developing during its manipulation for enzyme production. Therefore, the organism cannot be awarded QPS status.
3.3.
'Chryseobacterium proteolyticum'
Identity
The species 'Chryseobacterium proteolyticum' has been proposed by Yamaguchi and Yokoe (2000) , describing a single strain of the phylum Bacteroidetes, isolated from soil, which produces a proteindeamidating enzyme. DNA-DNA relatedness data and 16S rDNA sequence analysis indicated that this strain belongs to the genus Chryseobacterium, but not to an already described species. However, the species 'Chryseobacterium proteolyticum' is not an approved bacterial name with standing in nomenclature.
Body of knowledge
The body of knowledge is limited. A search was done considering all years available in the literature databases, using the species name as search terms. Eight papers were retrieved and all refer to the strain producing the protein glutaminase enzyme.
Safety concerns
No safety concerns have been addressed for this microorganism. Scheuplein et al. (2007) evaluated the pathogenicity and toxigenic potential of the strain by intravenous and oral inoculation studies in mice. No evidence of adverse effect was detected in this study.
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Antimicrobial resistance
No information related to the presence of antimicrobial resistance determinants has been identified in 'Chryseobacterium proteolyticum'.
Conclusions on a recommendation for the QPS list
'Chryseobacterium proteolyticum' is not a valid species name and all the studies refer to a single strain. Consequently, this taxonomical unit cannot be considered for the QPS list.
3.4.
Geobacillus caldoproteolyticus
Identity
Geobacillus caldoproteolyticus was originally described by Chen et al. (2004) . The organism was isolated from sewage sludge in Singapore and described as strictly aerobic. A taxonomic revision of the genus Geobacillus proposed it to be accommodated, along with Geobacillus tepidamans, in the genus Anoxybacillus as Anoxybacillus caldiproteolyticus sp. nov. (Coorevits et al., 2012) . A. caldiproteolyticus sp. nov. can be classified by 16S rRNA gene sequence analysis, polar lipid and fatty acid analysis, phenotypic characterisation and DNA-DNA hybridisation experiments. Therefore, the correct taxonomic name for strains belonging to this genus is A. caldiproteolyticus.
Body of knowledge
Anoxybacillus caldiproteolyticus was described to produce an extracellular protease that remained active under certain growth conditions (pH range of 6.0-11.0 and a temperature range of 40-90°C, with an optimal pH of 8.0-9.0 and an optimal temperature of 70-80°C). It can be relevant as enzyme producer. The body of knowledge is very limited. A search considering all years available in the database was carried out and only three scientific papers describing different aspects (taxonomy and enzyme production) of the microorganism were identified.
Safety concerns
No safety concerns have been addressed for this microorganism.
Antimicrobial resistance
No information related to the presence of antimicrobial resistance determinants has been identified in A. caldiproteolyticus.
Conclusions on a recommendation for the QPS list
Due to the lack of sufficient body of knowledge on a safe history of use or presence in foods and feeds, Geobacillus caldoproteolyticus (Anoxybacillus caldiproteolyticus sp. nov.) is not recommended for the QPS list.
3.5.
Geobacillus pallidus
Identity
The microorganism was first described as Bacillus pallidus by Scholz et al. (1987) . A close examination of the published characteristics of B. pallidus together with the morphological description and with the sequence similarity for the 16S rRNA gene available on the European Bioinformatics Institute database and with Geobacillus isolates obtained from soil strongly suggests that B. pallidus should be transferred and renamed Geobacillus pallidus comb. nov. (Banat et al., 2004) . In a later study, it was concluded, primarily based on the chemotaxonomic data, that strain CW 7(T) did not belong to the genus Bacillus, but should be placed in a new genus, for which the name Falsibacillus gen. nov. is proposed (Zhou et al., 2009 ). Finally, due to its low similarity in the 16S rRNA gene sequences to Anoxybacillus, Geobacillus and Bacillus subtilis and differences also on DNA G + C content, and fatty acid and polar lipid profiles, it was proposed that G. pallidus should be reclassified in a novel genus. The name Aeribacillus pallidus gen. nov., comb. nov. was proposed. The type strain of A. pallidus is H12(T) (Miñana-Galbis et al., 2010) . Therefore, the correct taxonomic name for strains belonging to this genus is A. pallidus.
Body of knowledge
Geobacillus pallidus was originally isolated from thermophilic treated wastes and is commonly isolated in the soil. Its presence in foods is not documented. It has been employed in studies of thermostable enzymes and of biodegradation including breakdown of 2-propanol (Bustard et al., 2002) . It converts amides to the corresponding acids and ammonia, and has application as an industrial catalyst (Agarkar et al., 2006) . It has also been shown to be able to produce bioemulsifiers on different hydrocarbons (such as oils) (Zheng et al., 2011) . Synthesis of innovative EPS by A. pallidus was also reported (Radchenkova et al., 2013) .
Safety concerns
A thermophilic G. pallidus SAT4 was found to produce an antimicrobial polipeptide, active against Micrococcus luteus ATCC 10240, Staphylococcus aureus ATCC 6538, B. subtilis NCTC 10400 and Pseudomonas aeruginosa ATCC 49189 (Muhammad et al., 2014) . No information related to the safety of A. pallidus has been published.
Antimicrobial resistance
No information related to the presence of antimicrobial resistance determinants has been identified in A. pallidus.
Conclusions on a recommendation for the QPS list
Due to the lack of sufficient body of knowledge on a safe history of use or presence in foods and feeds, Aeribacillus pallidus (ex-Geobacillus pallidus) is not recommended for the QPS list.
3.6.
Lactobacillus diolivorans 3.6.1. Identity
The species Lactobacillus diolivorans, first described by Krooneman et al. (2002) , belongs to the group of obligate heterofermentative lactobacilli. The phylogenetic analysis of the 16S rRNA indicates that this species belong to the Lactobacillus buchneri group.
Body of knowledge
A search for the body of knowledge on L. diolivorans was done considering all years available in the literature databases using the species name as search terms. A limited number of papers (32) were retrieved. This species was originally isolated from maize silage and it has been found in several foods of plant origin, such as apple juice, sourdough, pickles and tofu. The organism has been isolated also from kefir grains.
Safety concerns
No reports were found on safety concerns related to this Lactobacillus species in the literature database searches. As members of this species were in the past probably assigned to L. buchneri, a species granted the QPS status, additional safety concerns related to misidentification are not expected.
Antimicrobial resistance
No information related to the presence of antimicrobial resistance determinants has been identified in L. diolivorans.
Conclusions on a recommendation for the QPS list
The species Lactobacillus diolivorans is a natural component of bacterial communities of fermented vegetables and plant-derived products. It has never been implicated in human or animal diseases and therefore can be recommended for the QPS list. Klebsiella pneumoniae, a Gram-negative rod, is a member of Enterobacteriaceae family. Following taxonomic studies of the genus, based on 16S rDNA and DNA-DNA hybridisation, this species was reassigned as Klebsiella pneumoniae subsp. pneumoniae, Klebsiella pneumoniae subsp. ozaenae and Klebsiella pneumoniae subsp. rhinoscleromatis (Caputo et al., 2015) . These three subspecies cause distinguishable diseases of the respiratory tract and are also differentiated by in vitro metabolic activities. Moreover, recent data from whole genome sequence analysis supports the claim that K. pneumoniae subsp. ozaenae and K. pneumoniae subsp. rhinoscleromatis are distinct species of the Klebsiella genus (Caputo et al., 2015) . Therefore, in this Statement, K. pneumoniae refers to Klebsiella pneumoniae subsp. pneumoniae.
Body of knowledge
Klebsiella pneumoniae is an opportunistic pathogen that can be carried asymptomatically in the intestinal tract, skin, nose and throat of healthy individuals but can also cause a range of infections in the community and hospitalised patients, most commonly pneumonia, wound, soft tissue or urinary tract infections. Dispersed in the environment, animals can also carry K. pneumoniae asymptomatically in the intestinal tract (Holt et al., 2015) . K. pneumoniae produces pullulanase, an important debranching enzyme (lipoprotein), that has been utilised in different industries to hydrolyse the a-1,6-glucosidic linkages in starch, amylopectin, pullulan and related oligosaccharides (Hii et al., 2012) .
Safety concerns
Klebsiella pneumoniae infections are common in the community where they can cause a wide range of infections, including serious community-acquired infections, such as pyogenic liver abscess, pneumonia, endogenous endophthalmitis and meningitis (Li et al., 2014) . Moreover, K. pneumoniae is a leading cause of hospital-acquired infections (especially urinary tract infections, respiratory tract infections and bloodstream-associated infections) commonly associated with a multidrug resistance profile (Jones, 2010) . A variety of virulence factors is of particular relevance for survival and immune evasion during infection, especially capsule polysaccharide, lipopolysaccharide, fimbriae, outer membrane proteins, siderophores and determinants for nitrogen utilisation (Li et al., 2014) . In a recent study, Holt et al. (2015) suggested that acquisition of siderophores and rmpA, a gene upregulating capsule expression, are relevant to the ability of K. pneumoniae to cause invasive disease in nonimmunocompromised patients. The ability to produce membrane vesicles containing different proteins and with immunomodulatory activity was also demonstrated (Lee et al., 2012) .
Antimicrobial resistance
Chromosomal core genome of K. pneumoniae encode bla SHV, a gene conferring resistance to amoxicillin, fosA, low level resistance to fosfomycin, and oqxAB that confers cross-resistance to olaquindox, chloramphenicol and the quinolones (Holt et al., 2015) . Moreover, several acquired antibiotic resistance genes have been increasingly observed in K. pneumoniae isolates of different origins (Ewers et al., 2014; Rodrigues et al., 2014) .
Conclusions on a recommendation for the QPS list
Klebsiella pneumoniae has been implicated in human infections and can be considered a source of antibiotic resistance determinants. Therefore, this species cannot be recommended for the QPS list.
3.8.
Paenibacillus macerans 3.8.1. Identity
The genus Paenibacillus was originally included within the genus Bacillus and reclassified as a separate genus in 1993 (Ash et al., 1993) . Paenibacillus macerans was designated previously Bacillus macerans. The bacterium is a Gram-positive, rod-shaped, endospore-forming, facultative anaerobe, periflagellated cell and has low G + C content.
A phylogenetic analysis using part of the 16S rRNA conserved sequence with part of the 16S-23S ITS hypervariable sequence was performed for the classification of Bacillus species and related genera and to infer the phylogenetic relationships between 46 Bacillaceae species (Xu and Côt e, 2003) . A phylogenetically distinct cluster grouped several Paenibacillus species including P. macerans.
A 16S rDNA-targeted PCR for the detection of P. macerans has been developed (Voll u et al., 2003) .
Body of knowledge
Paenibacillus macerans is isolated from multiple environments, such as soil, water and vegetables (Logan and De Vos, 2011) . P. macerans is present in the rhizosphere and some strains show nitrogenfixing capability (Witz et al., 1967) . It is able to secrete a wide variety of different active substances against phytopathogenic bacteria and EPS with diverse physiological and biotechnological functions in industrial processes and wastewater treatment (Logan and De Vos, 2011) . It is a producer of enzymes (e.g. chitinases, amylases and proteases) and antimicrobial substances (antibiotics, bacteriocins and/or small peptides) (Fogarty, 1983) . Some strains are also able to produce antimicrobial substances against phytopathogenic bacteria and fungi (Fogarty, 1983) . P. macerans has been used to decompose cellulose from wheat (Halsall and Gibson, 1985) .
Safety concerns
There are few reports linked to infection caused by B. macerans or P. macerans. A report on P. macerans as cause of pseudobacteremia in neonates from contaminated blood culture bottles (environmental contamination of the rubber stoppers in blood culture bottles) has been published (Noskin et al., 2001 ). In former reports on isolations from clinical samples, the identification obtained is B. macerans (Bert et al., 1995; Barrero et al., 1996) . Logan (1988) reviewed the medical importance of Bacillus species and found only one case of human infection due to B. macerans.
Antimicrobial resistance
No information could be found about the presence of antimicrobial resistance determinants in P. macerans.
Conclusions on a recommendation for the QPS list
Due to the lack of sufficient body of knowledge on a safe history of use or presence in foods and feeds, Paenibacillus macerans is not recommended for the QPS list.
3.9.
Pediococcus parvulus 3.9.1. Identity
Pediococcus parvulus appears to be a well-defined species by 16S rRNA gene sequencing (Collins et al., 1990) . It clusters with other species of the genus, such as Pediococcus acidilactici, Pediococcus pentosaceus and Pediococcus damnosus (Collins et al., 1990) , which has been confirmed after comparison of the P. parvulus DSM20332 draft sequence (accession number: NZ_JQBE01000001) with those of representative strains of the other species (Sun et al., 2015) . Phylogenetically, the whole genus has been proposed to be allocated into the Lactobacillus genus complex together with genera Weisella, Leuconostoc, Oenococcus and Fructobacillus because in phylogenetic trees their species appear intermixed with those of Lactobacillus (Sun et al., 2015) .
Body of knowledge
Pediococcus parvulus is commonly associated with spoilage of alcoholic beverages because it commonly produces EPS and diacetaldehyde upon fermentation of the must sugars (Renouf et al., 2007; Petri et al., 2013; Delsart et al., 2016) . The former confers an oily appearance to the liquid known as ropiness, while the latter generates a butter-like flavour. In addition, some strains are histamine producers (Landete et al., 2005) . The EPS synthesising strains have been proposed as suitable for production of ropy dairy products (Elizaqu ıvel et al., 2011) but they have not been included in any commercial products. Similarly, it appears that EPS-producing strains are less susceptible to simulated and mice digestive conditions, while lowering the cholesterol levels (Immerstrand et al., 2010; Lindstr € om et al., 2013) reason why they have been proposed as potential probiotics but they were never used as such nor intentionally added to any food. P. parvulus is, however, frequently found in fermented foods (Mesas et al., 2011; Abriouel et al., 2012; Ba gder Elmacı et al., 2015) and feed, such as silage (Tohno et al., 2012) , and thus there is frequent exposure to it without any signs of pathogenicity for humans or animals.
Safety concerns
No communications on pathogenicity of P. parvulus were detected.
Antimicrobial resistance
Two reports on P. parvulus antibiotic resistance (Rojo-Bezares et al., 2006; Danielsen et al., 2007) provide similar data. The strains examined are highly susceptible to the b-lactams tested, but resistant to vancomycin, tetracycline, aminoglycosides, ciprofloxacin and trimethoprim. Genes conferring resistance to aminoglycosides (ant(6), aac(6 0 )-aph(2 00 )) and tetracyclines (tet(L)) have been detected but their expression or transmissibility was not tested.
Conclusions on a recommendation for the QPS list
Pediococcus parvulus can be granted the QPS status, being a species commonly found in fermented food and beverages and based on lack of pathogenicity as determined by the absence of any significant virulence determinants in its genome and of any reports on its role on human or animal infection.
3.10.
'Protaminobacter rubrum'
3.10.1. Identity 'Protaminobacter rubrum', is not an approved bacterial name with standing in taxonomy. Goulter et al. (2012) demonstrated that the organism used in most commercial production, patent and journal publications known as 'P. rubrum ' De Jong 1920 (CBS 574.77 ) has 99.9% identity to the type strain of Serratia plymuthica (a genus within the family of Enterobacteriaceae) over the full-length 16S rDNA sequence. Nevertheless, further genomic characterisation is required due to the lack of species resolution power of 16S rDNA gene within several genera.
Body of knowledge
'Protaminobacter rubrum' has been used in the EU since 1984 for the production of isomaltulose, a sugar replacer. The organism is used in an immobilised form for the production of the enzyme, isomaltulose mutase, which converts sucrose into isomaltulose. There is no information regarding the ability of 'P. rubrum ' De Jong 1920 (CBS 574.77) or other strains named 'P. rubrum' to produce antimicrobial compounds, in contrast with descriptions for S. plymuthica.
Safety concerns
Serratia plymuthica is a rare opportunistic pathogen causing a variety of infections including osteomyelitis, peritonitis, pneumonia, sepsis and wound infections.
The intravenous administration of approximately 2.2 9 10 8 viable 'Protaminobacter rubrum' De Jong 1920 (CBS 574.77) cells/rabbit (1 9 10 8 cells/kg) did not cause death or persistent disease. Similarly, in mice intravenous administration of approximately 2.5 9 10 9 viable 'P. rubrum' cells/mouse (8 9 10 10 cells/kg) did not cause death or persistent disease. In both animal experiments, 'P. rubrum' could not be recovered from blood or tissue cultures 14 days after treatment, indicating that the bacterial cells had been eliminated in vivo (Porter et al., 1991) .
Antimicrobial resistance
No information could be found about the presence of antimicrobial resistance determinants in S. plymuthica or 'P. rubrum'.
Conclusions on a recommendation for the QPS list
'Protaminobacter rubrum' is not a valid species name. Consequently, this taxonomical unit cannot be considered for the QPS list. 
Pullulanibacillus naganoensis
3.11.1. Identity Pullulanibacillus naganoensis was first described (Tomimura et al., 1990) under the name of Bacillus naganoensis as an obligate aerobic, moderately acidophilic, endospore-forming, Gram-positive bacterium. It was isolated on its ability to produce a thermostable, aciduric pullulanase (EC 3.2.1.41).
Analysis of its 16S rRNA sequence, chemotaxonomic properties and physiological characteristics indicated that it did not belong to the genus Bacillus and the new genus Pullulanibacillus was created with P. naganoensis having been designated as the type species (Hatayama et al., 2006) .
No partial or complete genome sequence of any strain of the species has been deposited in the databases.
Body of knowledge
The bibliography on P. naganoensis is extremely scarce. Apart from the already quoted articles that describe the general characteristics that define the species, the only other relevant literature refers to cloning and expression of the pullulanase gene in E. coli (Nie et al., 2013) . This, plus the lack of information on its complete sequence, make it impossible to ascertain whether this microorganism harbours any virulence factor genes, such as those encoding for toxins, adhesins, etc., and satellite replicons that might be able to transfer antimicrobial resistance genes, among others relevant for safety.
Safety concerns
No communications on pathogenicity of P. naganoensis have been recorded.
Antimicrobial resistance
No information could be found about the presence of antimicrobial resistance determinants in P. naganoensis.
Conclusions on a recommendation for the QPS list
The body of knowledge on Pullulanibacillus naganoensis is too limited to exclude the possibility of ill effects developing during its manipulation for enzyme production. Therefore, it cannot be awarded QPS status.
4.
Yeasts 4.1.
Candida rugosa

Identity
Candida rugosa is a member of the genus Candida. The genus comprises 314 species according to the last yeast taxonomic book (Kurtzman et al., 2011) and includes anamorphic ascomycetous yeasts that reproduce by multilateral budding. Many of the species are phenotypically similar and genotypically identical to species assigned to certain teleomorphic genera, whereas others are only known as anamorphs. As a result, this is a highly heterogeneous and polyphyletic genus also comprising species where teleomorphic states are still unknown.
The taxonomy has been complicated and using the knowledge gained from molecular studies there have recently been suggestions to divide C. rugosa into a species complex encompassing C. rugosa, Candida pseudorugosa, Candida neorugosa and Candida mesorugosa (Paredes et al., 2012; Padovan et al., 2013) . According to Kurtzman et al. (2011) , rRNA gene sequences of the type strain (CBS 613) is divergent from other strains of this species and the species belongs to a so far unaffiliated clade. Moreover, they also propose that the strain used most often for lipase production (CBS 6330) is actually the type strain of Candida cylindracea, which has resulted in confusion regarding lipase production properties in C. rugosa.
Body of knowledge
Candida rugosa has been associated with different biotechnological processes, but the most relevant one is the production of lipases. In the case of food processes, it has been described in cocoa fermentations (Boekhout and Robert, 2003) and in dairy products like Manteca or buttery whey cheese (Kurtzman et al., 2011) . However, in both biotechnology and food applications, some of the strains may have been misidentified and may belong to Candida pararugosa or C. cylindracea.
Safety concerns
Candida rugosa is often mentioned with the 'emerging' fungal pathogens (Hazen, 1995; Pfaller et al., 2006; Minces et al., 2009; Barton, 2011) . It is occasionally isolated from patients with fungal infections, mainly in blood or urinary tract. Barton (2011) noted that it is more commonly reported in Asia and Latin America than in Europe or US and speculated that the origin of infections with C. rugosa can be contaminated milk or food products. Pfaller et al. (2006) summarised information for Candida spp. isolates from medical centres from different parts of the world and supported the view that the prevalence of C. rugosa seems to increase. Another aspect regarding safety of C. rugosa is that it has been recurrently demonstrated to cause mastitis in, e.g. buffaloes and dairy cows (e.g. Scaccabarozzi et al., 2011; S ßeker and € Ozenc ß, 2011) . In some of these reports, there is a possibility that the strains might have been misidentified, which introduces uncertainty regarding reports of C. rugosa as an emerging opportunistic pathogen (Kurtzman et al., 2011) .
Antimicrobial resistance
Some information is available about the antimicrobial resistance of C. rugosa. Pfaller et al. (2006) analysed in vitro the susceptibility to fluconazole and voriconazole of 452 isolates of C. rugosa from different geographical regions and they observed a trend towards reduction in susceptibility to the azole antifungal agents. Padovan et al. (2013) reviewed four available studies, and based on the discrepancies of results concluded that the high reported variability of antifungal susceptibility within the C. rugosa complex may be related to both geographic and inter-and intraspecific variations.
Conclusions on a recommendation for the QPS list
Although Candida rugosa has sometimes been reported to occur in food fermentations due to an unclear taxonomy, it may have been misidentified in several of those cases. Moreover, it has recently been described as an 'emerging' human fungal pathogen and is well-known for causing mastitis. For these reasons, C. rugosa is not recommended for QPS status.
Conclusions
ToR 1: Keep updated the list of biological agents being notified, in the context of a technical dossier to EFSA Units (such as Feed, Food Ingredients and Packaging (FIP), Nutrition and Pesticides), for intentional use in feed and/or food or as sources of food and feed additives, enzymes and plant protection products for safety assessment:
• Between September 2015 and March 2016, 129 notifications were received from those four Units, of which 21 from Feed, 67 from FIP, two from Nutrition and 39 from Pesticides.
ToR 2: Review taxonomic units previously recommended for the QPS list and their qualifications (especially the qualification regarding antimicrobial resistance) when new information has become available:
• The work being developed in order to reply to this ToR is not reflected in the current Panel Statement.
• This ToR is being dealt with by the QPS working group and the ongoing revision of the overall assessment of the biological agents included in the 2013 QPS update Opinion will be published through a scientific opinion of the BIOHAZ Panel in December of 2016.
ToR 3: (Re)assess the suitability of taxonomic units notified to EFSA not present in the current QPS list for their inclusion in that list:
• Of the 129 notifications received, 34 biological agents already had a QPS status and did not require further evaluation.
• From the remaining 95 notifications (without a QPS status), 63 were not further assessed as they are filamentous fungi or enterococci, biological groups which have been excluded from QPS activities since 2014. Four notifications of strains belonging to Escherichia coli were also not evaluated because the species has not been recommended for the QPS approach. Five notifications for Streptomyces spp. were not included because several species of the genus were already evaluated in the previous Statement of December of 2014 and found unsuitable for QPS. One notification corresponding to a species of Actinomadura and one to Paenibacillus lentus were not included because they have already been evaluated in the Statement of December 2014 and were found unsuitable for QPS. Furthermore, agreement was reached with the Pesticides Unit not to include nine notifications as the respective dossiers (including the literature review) have not been received. Twelve notifications were considered for the assessment of the suitability of the respective taxonomic units for inclusion in the QPS list.
• From the twelve assessed taxonomic units, two were notified to the Feed Unit (Lactobacillus diolivorans and Pediococcus parvulus) and the other 10 to the FIP Unit (Bacillus flexus, Cellulosimicrobium cellulans, 'Chryseobacterium proteolyticum' , Geobacillus caldoproteolyticus, Aeribacillus pallidus (ex-Geobacillus pallidus), Klebsiella pneumoniae, Paenibacillus macerans, 'Protaminobacter rubrum', Pullulanibacillus naganoensis and Candida rugosa).
Recommendations
• Pediococcus parvulus and Lactobacillus diolivorans may be recommended for QPS status.
Bacillus flexus may be also recommended but with a qualification of absence of toxigenic activity (as applied to all strains of Bacillus species recommended for inclusion on the QPS list).
• Cellulosimicrobium cellulans, 'Chryseobacterium proteolyticum' , Geobacillus caldoproteolyticus (Anoxybacillus caldiproteolyticus), Aeribacillus pallidus (ex-Geobacillus pallidus), Klebsiella pneumonia, Paenibacillus macerans, 'Protaminobacter rubrum' , Pullulanibacillus naganoensis and Candida rugosa are not recommended for the QPS list.
Abbreviations and Glossary
Antimicrobial Any substance of natural, semisynthetic or synthetic origin that kills or inhibits the growth of microorganisms but causes little or no damage to the host. 
